Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ASP Isotopes (ASPI) Assets (2022 - 2025)

ASP Isotopes has reported Assets over the past 4 years, most recently at $498.0 million for Q4 2025.

  • On a quarterly basis, Assets rose 427.85% to $498.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $498.0 million, a 427.85% increase, with the full-year FY2025 number at $498.0 million, up 427.85% from a year prior.
  • Assets reached $498.0 million in Q4 2025 per ASPI's latest filing, up from $225.9 million in the prior quarter.
  • The five-year high for Assets was $498.0 million in Q4 2025, with the low at $9.5 million in Q3 2022.
  • The 4-year median for Assets is $50.1 million (2024), against an average of $94.1 million.
  • Peak YoY movement for Assets: grew 25.21% in 2023, then skyrocketed 608.64% in 2024.
  • Tracing ASPI's Assets over 4 years: stood at $12.5 million in 2022, then skyrocketed by 120.4% to $27.5 million in 2023, then skyrocketed by 242.56% to $94.3 million in 2024, then surged by 427.85% to $498.0 million in 2025.
  • According to Business Quant data, Assets over the past three periods came in at $498.0 million, $225.9 million, and $135.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.